CytomX Therapeutics (CTMX) Revenue Growth (1y) (2015 - 2026)
CytomX Therapeutics (CTMX) Revenue Growth (1y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Revenue Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
37.90% |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
64.24% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
7.82% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
CytomX Therapeutics |
520.30 Mn |
173.59 Mn |
- |
-79.85% |
| Date | Value |
|---|
| Mar 31, 2026 |
-79.85% |
| Dec 31, 2025 |
-98.26% |
| Sep 30, 2025 |
-82.16% |
| Jun 30, 2025 |
-25.71% |
| Mar 31, 2025 |
22.80% |
| Dec 31, 2024 |
43.17% |
| Sep 30, 2024 |
26.71% |
| Jun 30, 2024 |
1.58% |
| Mar 31, 2024 |
76.45% |
| Dec 31, 2023 |
32.22% |
| Sep 30, 2023 |
136.69% |
| Jun 30, 2023 |
92.36% |
| Mar 31, 2023 |
159.94% |
| Dec 31, 2022 |
80.77% |
| Sep 30, 2022 |
21.31% |
| Jun 30, 2022 |
46.14% |
| Mar 31, 2022 |
10.28% |
| Dec 31, 2021 |
57.28% |
| Sep 30, 2021 |
23.08% |
| Jun 30, 2021 |
25.86% |
